Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Senate Panel Questions Early PBM Response To Repatha Price Cut

Apr 10 2019

• By Cathy Kelly

Capitol House

Related Content

Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives

Jul 16 2018

PBMs Were On Capitol Hill, But Pharma Still Took Some Heat

Apr 10 2019

Insulin Manufacturers, PBMs To Face US House Subcommittee Grilling On Drug Pricing

Apr 02 2019

Making The Case For Rebates: UnitedHealth Pushing Expansion Of POS Program

Mar 14 2019

Amgen Drops Repatha List Price 60% To Cut Medicare Co-Pays And Boost Use

Oct 25 2018

Related Companies

Amgen, Inc.

Express Scripts Holding Company

Cigna Corp.

CVS Health Corp.

OptumRx Inc.

Humana Inc.

Additional Topics

United States Reimbursement Pricing Debate Legislation BioPharmaceutical

More from Market Access

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window